Abdominal pain upper and Disturbance in attention

Summary:

Disturbance in attention is found among people with Abdominal pain upper, especially for people who are female, 60+ old.

The study analyzes which people have Disturbance in attention with Abdominal pain upper. It is created by eHealthMe based on reports of 52 people who have Abdominal pain upper from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Abdominal pain upper?

Abdominal pain upper is found to be associated with 2,964 drugs and 4,494 conditions by eHealthMe. Check the latest studies of Abdominal pain upper.

What is Disturbance in attention?

Disturbance in attention is found to be associated with 1,770 drugs and 1,970 conditions by eHealthMe. Check the latest studies of Disturbance in attention.



On Aug, 03, 2026

52 people who have Abdominal Pain Upper and Disturbance In Attention are studied.

Would you have Disturbance in attention when you have Abdominal pain upper?

Gender of people who have Abdominal Pain Upper and experienced Disturbance In Attention *:

  • female: 85.71 %
  • male: 14.29 %

Age of people who have Abdominal Pain Upper and experienced Disturbance In Attention *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 30.43 %
  • 30-39: 8.7 %
  • 40-49: 2.17 %
  • 50-59: 21.74 %
  • 60+: 36.96 %

Common co-existing conditions for these people *:

  1. Pain: 19 people, 36.54%
  2. Hypersensitivity: 5 people, 9.62%
  3. High Blood Pressure: 4 people, 7.69%
  4. Sleep Disorder: 3 people, 5.77%
  5. Pulmonary Mass: 3 people, 5.77%
  6. Bone Density Abnormal: 3 people, 5.77%
  7. Rosacea (a skin condition that causes facial redness): 3 people, 5.77%
  8. Eczema (patches of skin become rough and inflamed, with itching and bleeding blisters): 3 people, 5.77%
  9. Vasculitis (inflammation of a blood vessel or blood vessels): 3 people, 5.77%
  10. Fibromyalgia (a long-term condition which causes pain all over the body): 3 people, 5.77%

Common drugs taken by these people *:

  1. Keppra: 15 people, 28.85%
  2. Vimpat: 14 people, 26.92%
  3. Fycompa: 13 people, 25.00%
  4. Lyrica: 6 people, 11.54%
  5. Paracetamol: 4 people, 7.69%
  6. Septra: 3 people, 5.77%
  7. Pantoprazole: 3 people, 5.77%
  8. Benadryl: 3 people, 5.77%
  9. Alvesco: 3 people, 5.77%
  10. Ventolin: 3 people, 5.77%

Common symptoms for these people *:

  1. Fatigue (feeling of tiredness): 27 people, 51.92%
  2. Dizziness: 26 people, 50.00%
  3. Headache (pain in head): 23 people, 44.23%
  4. Gait Disturbance: 18 people, 34.62%
  5. Memory Loss: 18 people, 34.62%
  6. Drug Intolerance (drug sensitivity): 17 people, 32.69%
  7. Appetite - Decreased (decreased appetite occurs when you have a reduced desire to eat): 17 people, 32.69%
  8. Muscle Twitching: 17 people, 32.69%
  9. Weight Decreased: 16 people, 30.77%
  10. Learning Disorder (the brain's disability to receive, process, store, respond to and communicate information): 14 people, 26.92%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Disturbance in attention?

- Check whether Disturbance in attention is associated with a drug or a condition


Related studies:

Treatments, associated drugs and conditions:

All the drugs that are associated with Disturbance in attention:

All the conditions that are associated with Disturbance in attention:


How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Disturbance in attention and Abdominal pain upper, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: